GoodRx Holdings, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GDRX research report →
Companywww.goodrx.com
GoodRx Holdings, Inc. , through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States.
- CEO
- Wendy Barnes
- IPO
- 2020
- Employees
- 738
- HQ
- Santa Monica, CA, US
Price Chart
Valuation
- Market Cap
- $873.51M
- P/E
- 41.75
- P/S
- 1.11
- P/B
- 1.38
- EV/EBITDA
- 3.98
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 86.56%
- Op Margin
- 10.73%
- Net Margin
- 2.61%
- ROE
- 3.31%
- ROIC
- 3.26%
Growth & Income
- Revenue
- $796.85M · 0.57%
- Net Income
- $30.44M · 85.72%
- EPS
- $0.09 · 100.94%
- Op Income
- $87.49M
- FCF YoY
- 44.77%
Performance & Tape
- 52W High
- $5.81
- 52W Low
- $1.77
- 50D MA
- $2.30
- 200D MA
- $3.02
- Beta
- 1.55
- Avg Volume
- 2.32M
Get TickerSpark's AI analysis on GDRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Chan Thomas (TC) | other | 2,637 |
| May 15, 26 | Chan Thomas (TC) | other | 1,686 |
| May 15, 26 | Chan Thomas (TC) | other | 1,686 |
| May 15, 26 | Chan Thomas (TC) | other | 2,637 |
| May 15, 26 | Chan Thomas (TC) | other | 858 |
| May 15, 26 | Chan Thomas (TC) | other | 1,342 |
| May 15, 26 | Chan Thomas (TC) | other | 1,252 |
| May 15, 26 | Chan Thomas (TC) | other | 638 |
| May 15, 26 | Chan Thomas (TC) | other | 1,252 |
| May 15, 26 | McGinnis Christopher A | other | 44,779 |
Our GDRX Coverage
We haven't published any research on GDRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GDRX Report →